We're ready to change pet
medicine ![]()
Searching worldwide to find the latest technology and research, we’re developing cutting-edge animal medicines and medical diagnostics. And we’re just getting started.
Helpful Reads
Can Dogs Relearn a Behavior or Command Without Confusion?
Handling tips for fast, large-striding agility dogs
HOW IT WORKS
How we’re starting
Helping pets with osteoarthritis
Our first innovative solution is to improve the lives of pets suffering from osteoarthritis with an all-new treatment. We have the option to license with Royal Vet College to develop a groundbreaking, patented technology using a compound called Hylin.
For interested & curious vets
Want to learn more about the science behind our first solution? This novel compound inhibits hyaluronan overproduction using a hyaluronan production inhibitor. We would love to hear any of your questions and gain your support.
Join the movement!
Excited to see how this solution can improve the lives of our beloved pets or your clients? Your support can help us get these solutions produced and available for all our furry friends.
Our PawsPack is growing
And we’re excited to see what we can accomplish next, together.
What are Common Mistakes to Avoid When Training a Puppy?
From Heatstroke to Pool Parties, Surviving the Heat with Dogs in the Summer
5 Best Practices for Veterinarians with Service Dog Patients
How Does K9 Basics Keep Dogs Safe During Scorching Hot Days?
Connect with our Experts
We’d love to hear from you! Our team can help you learn more about our current research and development status, dig deeper into the science, and more.
Our beloved pets need help
The pet medication market is growing fast and for a good reason. More pets are suffering from illnesses like diabetes, obesity, and arthritis pain that impact their quality of life.
Every 1 out of 3 dogs1 is suspected to be suffering from arthritis pain and up to 90% of cats.2 That’s why we’re starting with developing our osteoarthritis solution in partnership with Royal Vet College, to treat this common and often debilitating pet illness.
Getting your product to market
With the support of fellow pet experts like veterinarians and our valued investors, we can help get our flagship Hylin-based solution to more families, pets, and veterinary clinics, faster.
Tackling other pet health problems
Paws Pharma isn’t stopping at osteoarthritis solutions. We continue to evaluate our technologies pipeline, expand our partnerships, and work with our expert team to explore emerging chronic pet illness needs.
1. “Putting Pet Health First: Chronic Illness in Dogs and Cats.” Iman Ghosh and Alejandra Dander. Accessed Jan 24, 2023.
2.“Companion Animal Arthritis Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats), By Indication, By Treatment, By Distribution Channel, By Region, And Segment Forecasts, 2023–2030.” Grandview Research. Accessed Jan. 24, 2023.
Meet our team working on pet health innovations 
Kal Malhi
An experienced entrepreneur with a knack for working together with academia to advance impactful technology and fundraising capital for startups. To date Kal has secured over $300 million in capital for startups.
Rauni Malhi
Thanks to Rauni’s vast experience with corporate compliance and regulatory affairs in international capital markets, her expert council has been key in the development of BullRun Capital Inc and now, Paws Pharma.
Mike Steir
With 15 years of focus on building expertise in capital markets, business management and finance expert Mike is experienced with corporate structure, business development, IPO’s, M&As, and wealth management.
Nihar R. Pandey, Ph.D.
With more than 25 years of experience in life sciences and pharmaceuticals R&D from academia and industry combined, Nihar is considered one of the leading KOLs in drug discovery, development, and approvals.
Harry Nijjar
Harry is responsible for the preparation of consolidated financial statements, MD&A, and reporting packages for a wide range of clients in various industries. He is also one of the firm’s co-leads in developing and executing Malaspina’s corporate marketing initiatives.
Nancy Boufeas
A corporate paralegal with more than 25 years of experience in Civil Litigation and Corporate/Business Law, Nancy lends her legal and administration expertise to 200+ private companies plus several public companies trading on the CSE and TSX-V.
Our talented veterinary partners
We are excited to partner with the world-renowned Royal Veterinary College of London on our innovative pet health solutions.
A treat for your inbox
Join our community and stay up-to-date on the latest Paws Pharma news, get training tips from our experts, find nutrition advice, and more.
